Severity of COVID-19: Causes and Consequences — From Obesity to Chronic Fatigue Syndrome by Arāja, Diāna et al.
INTRODUCTION
In Latvia, incidence of the COVID-19 was relatively low
during the first six months of infection intervention
(March–August, 2020), but the epidemiological data of the
following months showed a sharp increase in morbidity. In
these circumstances, the importance of identifying and ana-
lysing the factors influencing the course of the disease is
growing. Accordantly, the National Research Programme
“COVID-19 Mitigation” project VPP-COVID-2020/1-0023
“Clinical, Bio-Chemical, Immunogenetic Paradigms of
COVID-19 Infection and Their Correlation With Socio-
Demographic, Etiological, Pathogenetic, Diagnostic, Thera-
peutically, and Prognostically Relevant Factors to Be In-
cluded in the Guidelines” was dedicated to identification of
relevant factors correlated with COVID-19 infection para-
digms. Within the scope of this project (inter alia),
COVID-19 patients were surveyed and several biological
parameters were determined during the recruitment of pa-
tients to the National Biobank — Genome Database of the
Latvian population, maintained by the Latvian Biomedical
Research and Study Centre. The preliminary data indicated
several predispositions, such as overweight and obesity. At
the same time, the study aimed to assess not only the
causes, but also the consequences of COVID-19, and the
survey was supplemented with additional questions to iden-
tify potential patients with chronic conditions such as the
post-viral chronic fatigue syndrome (CFS). Rîga Stradiòð
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In circumstances of COVID-19 epidemiological uncertainty, the causes and consequences of the
disease remain important issues. The aim of this study was to investigate obesity as a potential
predisposition and chronic fatigue syndrome (CFS) as a possible consequence of COVID-19. The
study was conducted in two parts: a theoretical part, in which a literature review was performed,
and an empirical part, in which COVID-19 patient survey data were analysed. To identify the main
findings regarding the relationship between obesity and COVID-19, the literature review was fo-
cused on the investigation of systematic reviews and meta-analyses by three databases — Med-
line (via PubMed), Cochrane COVID-19 Study Register, and PROSPERO (International
prospective register of systematic reviews). The patient survey was performed to investigate the
relationship between obesity and severity of the disease, as well as the presence of CFS symp-
toms in COVID-19 patients in Latvia. The main findings of the literature review showed that obe-
sity increases the risk of hospitalisation, disease severity, clinical complications, poor outcomes,
and mortality. The results of the patient survey showed that overweight and obesity were more
critical factors for men (males) suffering with COVID-19 than for women (females) in Latvia. The
patient group with obesity caused almost half of all hospitalisations. The research data assumed
that CFS patients were not a high-risk group for COVID-19, but COVID-19 caused CFS-like
symptoms in patients and potentially increased the number of undiagnosed patients. In the con-
text of further epidemiological uncertainty and the possibility of severe post-viral consequences,
preventive measures are becoming increasingly important.
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University performed an analysis of the obtained data with
the aim to investigate the causes and consequences of
COVID-19 in Latvian circumstances. In light of this re-
search, a scientific literature review was performed to ob-
tain comparative data on impact of overweight on the
course and severity of the COVID-19 disease.
MATERIALS AND METHODS
The study consisted of two parts: a theoretical part, in which
a literature review was performed, and an empirical part, in
which the COVID-19 patient survey data were analysed.
The survey data were obtained from the COVID-19 patients
cohort established at the National Biobank – Genome Data-
base of the Latvian population (Rovite et al., 2018). The
synthesis of these two parts should serve the aim of the re-
search.
In the theoretical part, the purpose was to identify the main
findings regarding the relationship between obesity and
COVID-19, and the search was focused on systematic re-
views and meta-analyses in databases. A search was per-
formed in three databases — Medline (via PubMed),
Cochrane COVID-19 Study Register, and PROSPERO (In-
ternational prospective register of systematic reviews) —
without time period restrictions. The following search key
words were used in all databases without any other filters or
restrictions: (“COVID-19”) OR (“coronavirus”) OR
(“SARS-COV-2”) AND (“body mass index”) OR (“BMI”)
OR (“obesity”) OR (“overweight”) AND (“systematic re-
view”) OR (“meta-analysis”). The flow diagram of the stud-
ies selection process is shown in Figure 1.
To achieve the purpose of the empirical part — to investi-
gate the relationship between obesity and severity of the
COVID-19 disease in Latvian patients — the following
tasks were defined:
– to determine the Body Mass Index (BMI) of patients par-
ticipating in the project,
– to compare the obtained data with the relevant data of the
Latvian population,
– to investigate the relationship of BMI and severity of the
disease.
In order to compare the obtained data with the relevant data
on the BMI in the Latvian population, the data of the Dis-
eases Prevention and Control Centre’s Report “Health Be-
haviour Among Latvian Adult Population, 2018” were used
(Latvian DPCC, 2019). The comparison was performed by
age categories defined in the Report (15–24, 25–34, 35–44,
45–54, 55–64, 65–74 years) (Latvian DPCC, 2019).
Within the scope of this study, the standard BMI categories
were used for adults: “Underweight =< 18.5”; “Normal
weight = 18.5–24.9”; “Overweight = 25–29.9”, and “Obe-
sity = BMI of 30 or greater”. For children until 19 years, the
specific interpretation of BMI was used in accordance with
the World Health Organisation’s “SD Scores for BMI Chil-
dren 5–19 years”.
Hospitalisation was used as a criterion of disease severity.
The questionnaire for the purpose to identify potential CFS
patients contained additional questions on CFS relevant
symptoms, laboratory investigations, and quality of life.
Descriptive statistical methods were utilised for analyses of
the obtained data.
Patient’s informed consent was obtained in accordance with
the Central Medical Ethics Committee’s approval No 01-
29.1/5034.
RESULTS
In context of the theoretical research, the flow diagram of
the selection process for systematic reviews and meta-
analyses is shown in Figure 1.
A total of 80 articles were identified using the search strate-
gies (Fig. 1). After the removal of duplicates using refer-
ence management software (EndNote, Clarivate Analytics),
66 articles studies were then screened for title and abstract
and 30 were excluded due to the status “Review Ongoing”.
The remaining 36 articles were screened against eligibility
criteria. 24 full-text articles were excluded (16 were without
methodology of systematic review or meta-analysis, and 8
reviews covered only specific countries, therefore they were
not sufficiently eligible for objective evaluation).
The main findings of the review are presented in a summary
of findings table (Table 1). This table provides key informa-
tion concerning the research authors, number of covering
Fig. 1. Flow diagram of the selection process for systematic reviews and
meta-analyses on relationship between obesity and COVID-19 prognosis.
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articles (or studies), and the sum of available data on the
main outcomes.
The time period for literature was not defined, but the real
systemic reviews and meta-analyses started to appeared in
June 2020 and continued until the end of 2020 (the current
study was completed by December 2020).
In the empirical part of the study on investigation of the re-
lationship between obesity and severity of the COVID-19
disease in Latvian patients, the data of 190 women (female)
and 123 men (male) were investigated. The data of the com-
parative analysis between the prevalence of BMI in the
overall Latvian population and patient groups, in each of the
defined age categories, are shown in Figure 2 for females
and in Figure 3 for males.
Figures 2 and 3 indicate the age categories in which the
BMI of the patient group exceeded that of the overall Lat-
vian population and which can indicate risk groups in both
the female and male populations. In Table 2, the data on
hospitalisations as a COVID-19 disease severity criterion
are shown.
The most critical values are marked in bold in Table 2. High
importance is also given to the results showing that hospi-
talisation for the BMI category “Obesity = BMI of 30 or
greater” accounted for 46% of the total number of hospitali-
sations; the BMI categories “Overweight = 25–29.9” and
“Normal weight = 18.5–24.9” accounted for 28.1% of the
total number of hospitalisations; and 1.2% were for the BMI
category “Underweight =< 18.5”.
Table 1. Characteristics of the included systematic reviews and meta-analyses assessing severe COVID-19 according to Body Mass Index (BMI) and obesity









BMI was found to be higher in patients with severe disease than in those with mild or moderate disease in China. Ele-
vated BMI was associated with invasive mechanical ventilation (IMV) use in Western countries. Additionally, there
were increased odds ratios of IMV use and hospitalisation in patients with obesity. In conclusion, obesity or high BMI
increased the risk of hospitalisation, severe disease and IMV in COVID-19.
Yang, et al.,
2020, June
9 articles Results show that severe COVID-19 patients had a higher BMI than non-severe ones; COVID-19 patients with obesity





Obesity was a significant risk factor for intensive care unit (ICU) admission in a homogenous dataset, as well as for
IMV in COVID-19. Comparing BMI classes with each other, it was found that a higher BMI always carries a higher
risk. Obesity may serve as a clinical predictor for adverse outcomes.
Malik et al.,
2020, July
14 studies The results of the current study show that BMI plays a significant role in COVID-19 severity in all age groups, espe-
cially the older individuals. Study finding showed that the population and patients with high BMI have moderate to




14 studies Patients with obesity are at high risk of mortality from COVID-19 infection. All the primary points (including the age






Univariate analyses showed significantly higher ORs of severe COVID-19 with higher BMI: for hospitalisation, for
ICU admission, for IMV requirement, and for death. Multivariate analyses revealed increased ORs of severe
COVID-19 associated with higher BMI for the same positions. Conclusion: Obesity increases risk for hospitalisation,






Most of the included studies showed some degree of association to: (a) higher BMI and worse clinical presentation and
(b) obesity and need of hospitalisation. The results were inconsistent about the impact of obesity on mortality. Based




with data on of
4920 patients
Conclusions: Excess adiposity is a risk factor for severe disease and mortality in people with SARS-CoV-2 infection.
This was particularly pronounced in people 60 and older. It should be taken into account when considering individual
and population risks and when deciding on which groups to target for public health messaging on prevention and de-
tection measures.
Malik, P. et al.,
2020,
September
10 studies with 10
233 confirmed
COVID-19 patients
The overall prevalence of obesity in the study was 33.9%. In meta-analysis, COVID-19 patients with obesity had
higher odds of poor outcomes compared with better outcomes with a pooled OR, with 86% heterogeneity between










Conclusions: In the current review, obesity and overweight were represented an unfavourable factor for infection of
novel coronavirus, where the higher the BMI the worse the outcomes. This occurred by worsening the infection itself,
as well as increasing the prevalence of hospitalisations, worst outcomes and greater lethality; especially when co-oc-




16 studies Conclusion: Obesity is a risk factor of composite poor outcome of COVID-19. On the other hand, COVID-19 patients
with composite poor outcome have higher BMI. BMI is an important routine procedure that should always be assessed




22 studies (12 591
patients)
BMI was higher in severe/critical COVID-19 patients than in mild COVID-19 patients. Additionally, obesity in
COVID-19 patients was associated with poor outcomes, which comprised severe COVID-19, ICU care, IMV use, and
disease progression. Obesity as a risk factor was greater in younger patients. However, obesity did not increase the risk
of hospital mortality.
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Simultaneously, COVID-19 can induce long-lasting compli-
cations and chronic conditions such as the post-viral CFS,
which is a poorly understood, serious, complex, multi-
system disorder, characterised by symptoms lasting at least
six months, with severe incapacitating fatigue not alleviated
by rest, and other symptoms, many autonomic or cognitive
in nature, including profound fatigue, cognitive dysfunc-
tion, sleep disturbances, muscle pain, and post-exertional
malaise, which lead to substantial reductions in functional
activity and quality of life (Pheby et al., 2020).
For this reason, the questionnaire for the purpose to identify
the potential CFS patients contained additional questions on
the CFS relevant symptoms, laboratory investigations and
Fig. 2. Prevalence of BMI in the overall Latvian population, left column in each segment (Latvian DPCC, 2019), and patient groups, right column in each
segment (authors, 2020), in each of the defined age categories, for females
Fig. 3. Prevalence of BMI in the overall Latvian population, left column in each segment (Latvian DPCC, 2019), and patient groups, right column in each
segment (authors, 2020), in each of the defined age categories, for males
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quality of life. The data of this survey showed that none of
the 120 respondents was diagnosed with CFS, but 53 re-
spondents (44.2%) indicated at least one of the symptoms
characteristic of CFS. Of these 53 respondents, 20 respon-
dents (37.7%) reported 4 to 8 CFS specific symptoms si-
multaneously. Significantly, 19 of these 20 respondents
(95%) reported the launching of symptoms after COVID-
19, in the period from March 2020.
DISCUSSION
Due to topicality and variability of the situation, new scien-
tific publications have appeared, and the majority of rele-
vant studies identified that obesity increases the risk of hos-
pitalisation, disease severity, clinical complications, poor
outcomes, and mortality. Only one of 12 investigated arti-
cles indicated that obesity did not increase the risk of hospi-
tal mortality.
The data of this study survey showed that BMI of the
COVID-19 patients did not have strong relation to the BMI
data of overall Latvian population. The situation for men
(males) suffering from COVID-19 was more critical con-
cerning overweight and obesity, in comparison with
women (females) in Latvia.
The excess of BMI in the category “Obesity” for female pa-
tients compared to the overall Latvia female population was
observed in the age groups from 15 until 34 years, and in
the category “Overweight” for age groups from 25 to 34
years and from 55 to 64 years. Male patients had a much
higher prevalence of obesity — excess of BMI in the cate-
gory “Obesity” for male patients compared to the overall
Latvian male population was observed in the age groups
from 25 until 54 years and from 65 to 74 years. However,
the male age groups from 15 to 24 years, from 35 to 44
years and from 55 to 64 were represented by dominance of
the BMI category “Overweight”. It is remarkable that for
female patients in the age from 35 to 44 years the “Under-
weight” was characteristic, but for male patients this age
group was dominated by the categories “Overweight” and
“Obesity”.
The hospitalisations as a COVID-19 disease severity crite-
rion, by age category, showed that a critical situation in-
creased rapidly from the age of 65 years. However, the pa-
tient group with obesity caused almost half of all
hospitalisations.
The study data assumed that CFS patients are not a high-
risk group for COVID-19, but that COVID-19 disease
causes CFS-like symptoms in patients. This increases the
need for monitoring of patients for even longer after recov-
ering from COVID-19 symptoms, to prevent complications
and progression of chronic diseases, including CFS.
CONCLUSIONS
In the context of further epidemiological uncertainty and the
possibility of severe post-viral consequences, preventive
measures are becoming significantly important. The in-
creased risk of poor outcomes from COVID-19 disease in
people with obesity should be taken into account in
decision-making on individual and population risk preven-
tion and detection measures. Regular physical activities, a
balanced diet, and emotional stability can be effective tools
to mitigate, prevent, and avoid the COVID-19 conse-
quences.
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COVID-19 SMAGUMS: CÇLOÒI UN SEKAS — NO APTAUKOÐANÂS LÎDZ HRONISKÂ NOGURUMA SINDROMAM
COVID-19 epidemioloìiskâs nenoteiktîbas apstâkïos jautâjumi par slimîbas cçloòiem un sekâm joprojâm ir aktuâli. Ðî pçtîjuma mçríis bija
izpçtît aptaukoðanos kâ potenciâlu predispozîciju un hroniska noguruma sindromu (HNS) kâ iespçjamâs COVID-19 sekas. Pçtîjums tika
veikts divâs daïâs: teorçtiskajâ daïâ, kurâ tika veikts literatûras apskats, un empîriskajâ daïâ, kurâ tika analizçti COVID-19 pacientu aptaujas
dati. Lai identificçtu galvenos secinâjumus par aptaukoðanâs un COVID-19 saistîbu, literatûras pârskats tika koncentrçts uz sistemâtisku
pârskatu un meta-analîþu izpçti trîs datu bâzçs — Medline (caur PubMed), Cochrane COVID-19 Study Register un PROSPERO (Interna-
tional prospective register of systematic reviews). Pacientu aptauja tika veikta, lai izpçtîtu saistîbu starp aptaukoðanos un slimîbas
smagumu, kâ arî HNS simptomu klâtbûtni COVID-19 pacientiem Latvijâ. Galvenie literatûras pârskata secinâjumi liecina, ka aptaukoðanâs
palielina hospitalizâcijas, slimîbas smaguma, klînisko komplikâciju, nelabvçlîgu rezultâtu un mirstîbas iespçjamîbu. Pacientu aptaujas
rezultâti râda, ka vîrieðu, kuri cietuði no COVID-19, dati ir kritiskâki attiecîbâ uz lieko svaru un aptaukoðanos, salîdzinot ar sievieðu datiem
Latvijâ. Pacientu grupa ar aptaukoðanos izraisa gandrîz pusi no visâm hospitalizâcijâm. Pçtîjuma dati pierâda, ka HNS pacienti nav
COVID-19 augsta riska grupâ, tomçr COVID-19 pacientiem izraisa HNS lîdzîgus simptomus un potenciâli palielina nediagnosticçto
pacientu skaitu. Saistîbâ ar epidemioloìisko nenoteiktîbu un nopietnu pçcvîrusa seku iespçjamîbu preventîvie pasâkumi kïûst arvien
nozîmîgâki.
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